hc – -Translation – Keybot Dictionary

Spacer TTN Translation Network TTN TTN Login Deutsch Français Spacer Help
Source Languages Target Languages
Keybot 35 Results  www.cadth.ca
  Issue 5 | CADTH  
. Ottawa: Health Canada; 2008. Available from: http://www.hc-sc.gc.ca/dhp-mps/md-im/qualsys/list_liste_regist-eng.php
http://www.hc-sc.gc.ca/dhp-mps/md-im/activit/announce-annonce/md_notice_software_im_avis_logicels-fra.php
  Issue 12 | CADTH  
. Ottawa: Health Canada; 2010. Available: http://www.hc-sc.gc.ca/fn-an/nutrition/vitamin/vita-d-eng.php.
La Société canadienne du cancer annonce ses recommandations concernant la vitamine D
  Issue 5 | CADTH  
. Ottawa: Health Canada; 2009. Available from: http://www.hc-sc.gc.ca/dhp-mps/md-im/activit/announce-annonce/md_notice_software_im_avis_logicels-eng.php
Avis -Classification des logiciels de gestion de patients à distance (classe I et classe II).
  Pharmacologic-Based Str...  
In: Canadian Tobacco Use Monitoring Survey (CTUMS) 2007. Ottawa: Health Canada; 2008 [cited 2008 Nov 25]. Available from: http://www.hc-sc.gc.ca/hc-ps/tobac-tabac/research-recherche/stat/_ctums-esutc_2007/ann-eng.php.
Tableaux supplémentaires : annuel (février à décembre, 2007). Dans: Enquête de surveillance de l’usage du tabac au Canada (ESUTC) 2007. Ottawa: Santé Canada; 2008 [cité le 25 novembre 2008]. Accessible à : http://www.hc-sc.gc.ca/hc-ps/tobac-tabac/research-recherche/stat/_ctums-esutc_2007/ann-fra.php.
  Issue 12 | CADTH  
. [Information Update]. Ottawa: Health Canada; 2007. Available: http://www.hc-sc.gc.ca/ahc-asc/media/advisories-avis/_2007/2007_130-eng.php.
. Ottawa: Santé Canada; 2010. Accessible à : http://www.hc-sc.gc.ca/fn-an/nutrition/vitamin/vita-d-eng.php.
  Antithrombotic Agents f...  
38. Oldgren J, Alings M, Darius H, Diener HC, Eikelboom J, Ezekowitz MD, et al. Risks for stroke, bleeding, and death in patients with atrial fibrillation receiving dabigatran or warfarin in relation to the CHADS2 score: a subgroup analysis of the RE-LY Trial.
Oldgren J, Alings M, Darius H, Diener HC, Eikelboom J, Ezekowitz MD, et al. Risks for stroke, bleeding, and death in patients with atrial fibrillation receiving dabigatran or warfarin in relation to the CHADS2 score: a subgroup analysis of the RE-LY Trial. Ann Intern Med.
  Contact Us | CADTH  
Health Canada — For information regarding regulation and/or licensing approval, please contact Health Canada (www.hc-sc.gc.ca), the national governing body that provides licensing approval of medical technologies for use within Canada.
Santé Canada — Pour tout renseignement sur la réglementation et/ou l’homologation, communiquez avec Santé Canada (www.hc-sc.gc.ca), ministère responsable de l’homologation des technologies médicales utilisées au Canada.
  Issue 18 | CADTH  
Therapeutic Products Directorate annual report 2007-2008 [Internet]. Ottawa: Health Canada; [cited 2011 Feb 22]. Available from: http://www.hc-sc.gc.ca/dhp-mps/prodpharma/applic-demande/docs/tpd_rep_dpt_rap_2007-2008-eng.php
65. Direction des produits thérapeutiques. Direction des produits thérapeutiques Rapport annuel 2007-2008 [Internet]. Ottawa: Santé Canada; [cité le 22 février 2011]. Accessible à : http://www.hc-sc.gc.ca/dhp-mps/prodpharma/applic-demande/docs/tpd_rep_dpt_rap_2007-2008-fra.php
  Issue 8 | CADTH  
Update on reprocessing and reuse of single-use medical devices [Internet]. Ottawa: Health Canada, Therapeutics Product Directorate; 2007. [cited 2010 Jun 3]. Available from: http://www.hc-sc.gc.ca/dhp-mps/md-im/activit/announce-annonce/lthsud_md_lahimj_im-eng.php
Provincial Infectious Diseases Advisory Committee. Best practices for cleaning, disinfection and sterilization in all health care settings [Internet]. Toronto: Ontario Ministry of Health and Long-Term Care; 2009. [cited 2010 Jun 3]. Available from: http://www.health.gov.on.ca/english/providers/program/infectious/diseases/best_prac/bp_cds_2.pdf
  Antithrombotic Agents f...  
40. Hart RG, Diener HC, Yang S, Connolly SJ, Wallentin L, Reilly PA, et al. Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial.
Hart RG, Diener HC, Yang S, Connolly SJ, Wallentin L, Reilly PA, et al. Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial. Stroke.
  Recent HTAs and Canadia...  
Reporting adverse reactions to antiviral drugs during an influenza pandemic ― guidelines for health professionals and consumers. PHAC, 2009: http://www.hc-sc.gc.ca/dhp-mps/alt_formats/hpfb-dgpsa/pdf/medeff/2009_ar-ei_anti_guide-ldir-eng.pdf
La déclaration d’effets indésirables d’antiviraux lors d’une pandémie degrippe - Lignes directrices pour les professionnels de la santé et les consommateurs, ASPC, 2009: http://www.hc-sc.gc.ca/dhp-mps/alt_formats/hpfb-dgpsa/pdf/medeff/2009_ar-ei_anti_guide-ldir-fra.pdf
  Issue 15 | CADTH  
21. Van Alstyne J. News release: Government of Canada accepts recommendations on MS research [Internet]. Ottawa (ON): Health Canada; 2010 Sep 1. 2010-148. [cited 2010 Nov 15]. Available from: http://www.hc-sc.gc.ca/ahc-asc/media/nr-cp/_2010/2010_148-eng.php
Van Alstyne J. Communiqué de presse: Le gouvernement du Canada accepte les recommandations en matière de recherche sur la sclérose en plaques [Internet]. Ottawa (ON): Santé Canada; le 1er septembre 2010. 2010-148. [cité le 15 novembre 2010]. Accessible à : http://www.hc-sc.gc.ca/ahc-asc/media/nr-cp/_2010/2010_148-fra.php
  Robot-Assisted Surgery....  
In: Medical Devices Active Licence Listing (MDALL) [Internet]. Ottawa: Medical Devices Bureau, Therapeutic Products Directorate, Health Canada. Available from: http://www.hc-sc.gc.ca/dhp-mps/md-im/licen/mdlic-eng.php.
Santé Canada. Da Vinci Surgical System - Endoscopic instruments. 2008 [cité le 5 juillet 2011]. Dans: Liste des instruments médicaux homologués en vigueur (MDALL) [Internet]. Ottawa: Bureau des matériels médicaux, Direction des produits thérapeutiques, Santé Canada. Accessible à : http://www.hc-sc.gc.ca/dhp-mps/md-im/licen/mdlic-fra.php.
  Issue 20 | CADTH  
Government of Canada accepts recommendations on MS research [Internet]. Ottawa: Health Canada; 2010 Sep 1. [cited 2011 Apr 18]. Available from: http://www.hc-sc.gc.ca/ahc-asc/media/nr-cp/_2010/2010_148-eng.php
30. Government of Saskatchewan [Internet]. Saskatoon (SK): Government of Saskatchewan; c2011. News release: Province of Saskatchewan slates $5 million for MS liberation trials; 2010 Oct 19 [cité le 18 avril 2011]. Accessible à : http://www.gov.sk.ca/news?newsId=a14ba963-a810-45e4-9ffa-3f3bcf64148f
  Issue 10 | CADTH  
85. Peterson TE, Manning HC. Molecular imaging: 18F-FDG PET and a whole lot more. J Nucl Med Technol.
Luker G, Luker K. Optical imaging: current applications and future directions. J Nucl Med.
  Antithrombotic Agents f...  
36. Diener HC, Connolly SJ, Ezekowitz MD, Wallentin L, Reilly PA, Yang S, et al. Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial.
Diener HC, Connolly SJ, Ezekowitz MD, Wallentin L, Reilly PA, Yang S, et al. Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial. Lancet Neurol.
  Pharmacologic-Based Str...  
In: Canadian Tobacco Use Monitoring Survey (CTUMS) 2007. Ottawa: Health Canada; 2008 [cited 2008 Nov 25]. Available from: http://www.hc-sc.gc.ca/hc-ps/tobac-tabac/research-recherche/stat/_ctums-esutc_2007/ann-eng.php.
Tableaux supplémentaires : annuel (février à décembre, 2007). Dans: Enquête de surveillance de l’usage du tabac au Canada (ESUTC) 2007. Ottawa: Santé Canada; 2008 [cité le 25 novembre 2008]. Accessible à : http://www.hc-sc.gc.ca/hc-ps/tobac-tabac/research-recherche/stat/_ctums-esutc_2007/ann-fra.php.
  Issue 18 | CADTH  
Ottawa: Minister of Public Works and Government Services Canada; 2009 Sep 30. [cited 2011 Feb 22]. Available from: http://www.hc-sc.gc.ca/dhp-mps/alt_formats/hpfb-dgpsa/pdf/prodpharma/applic-demande/guide-ld/postnoc_change_apresac/noc_pn_framework_ac_sa_cadre-eng.pdf
66. Santé Canada. Guidance document.Post-notice of compliance (NOC) changes: framework document [Internet]. Ottawa: Ministère des travaux publics et des Services gouvernementaux; 2009 Sep 30. [cité le 22 février 2011]. Accessible à : http://www.hc-sc.gc.ca/dhp-mps/alt_formats/hpfb-dgpsa/pdf/prodpharma/applic-demande/guide-ld/postnoc_change_apresac/noc_pn_framework_ac_sa_cadre-eng.pdf
  Robot-Assisted Surgery....  
In: Medical Devices Active Licence Listing (MDALL) [Internet]. Ottawa: Medical Devices Bureau, Therapeutic Products Directorate, Health Canada. Available from: http://www.hc-sc.gc.ca/dhp-mps/md-im/licen/mdlic-eng.php.
Santé Canada. Da Vinci S Surgical System - Control for endoscopic instruments. 2008 [cité le 5 juillet 2011]. Dans: Liste des instruments médicaux homologués en vigueur (MDALL) [Internet]. Ottawa: Bureau des matériels médicaux, Direction des produits thérapeutiques, Santé Canada. Accessible à : http://www.hc-sc.gc.ca/dhp-mps/md-im/licen/mdlic-fra.php.
  Reprocessing of Single-...  
1. Sharma S. Update on reprocessing and reuse of single-use medical devices [Internet]. Ottawa: Health Canada, Therapeutic Products Directorate; 2007. [cited 2011 Jun 28]. Available from: http://www.hc-sc.gc.ca/dhp-mps/md-im/activit/announce-annonce/lthsud_md_lahimj_im-eng.php
5. Cause for concern: reuse of single-use medical devices. The case for Canadian regulations [Internet]. Toronto: MEDEC; 2010 Sep. [cité le 27 juin 2011]. Accessible à : http://www.medec.org/webfm_send/1152
  Issue 22 | CADTH  
Ottawa: Health Canada; 2010. Medical Isotopes - frequently asked questions; 2009 Aug 31 [cited 2010 Jul 15]. Available from: http://www.hc-sc.gc.ca/dhp-mps/brgtherap/activit/fs-fi/isotopes-med-faq-eng.php
Canadian Institute for Health Information. Health care in Canada 2009: a decade in review [Internet]. Ottawa: CIHI; 2010. [cited 2010 Dec 2]. Available from: http://secure.cihi.ca/cihiweb/products/HCIC_2009_Web_e.pdf
  Generic Drugs: Your Que...  
http://www.hc?sc.gc.ca/hl?vs/iyh?vsv/med/med?gen?eng.php.
Innocuité et efficacité des médicaments génériques
  Endovascular Therapy fo...  
Ottawa: Health Canada; August 8, 2012. The 2001 Progress Report on Tobacco Control; 2006 Jun 6 [cited 2012 Oct 29]. Available from: http://www.hc-sc.gc.ca/hc-ps/pubs/tobac-tabac/prtc-relct-2001/fig1-eng.php#a4
16. Health Canada. Tobacco - Reports and Publication [Internet]. Ottawa: Health Canada; August 8, 2012. The 2001 Progress Report on Tobacco Control; 2006 Jun 6 [cité le 29 octobre 2012]. Disponible au : http://www.hc-sc.gc.ca/hc-ps/pubs/tobac-tabac/prtc-relct-2001/fig1-eng.php#a4
  Issue 12 | CADTH  
. Ottawa: Health Canada; 2007. Available: http://www.hc-sc.gc.ca/fn-an/food-guide-aliment/context/vita_d-eng.php.
[Current Issues]. Toronto: Dietitians of Canada; 2008. Accessible à : http://www.onpen.ca/docviewer.asp?id=6993.
  Endovascular Therapy fo...  
Ottawa: Health Canada; August 8, 2012. The 2001 Progress Report on Tobacco Control; 2006 Jun 6 [cited 2012 Oct 29]. Available from: http://www.hc-sc.gc.ca/hc-ps/pubs/tobac-tabac/prtc-relct-2001/fig1-eng.php#a4
16. Health Canada. Tobacco - Reports and Publication [Internet]. Ottawa: Health Canada; August 8, 2012. The 2001 Progress Report on Tobacco Control; 2006 Jun 6 [cité le 29 octobre 2012]. Disponible au : http://www.hc-sc.gc.ca/hc-ps/pubs/tobac-tabac/prtc-relct-2001/fig1-eng.php#a4